It’s time for the second installment of our executive interview blog series. Today we’re chatting with Bob Loll, our senior vice president of business development and strategic planning. He’s been with us for just over nine wonderful years, is an all-too-familiar face on the conference circuit, and truly has a heart of gold. Here’s what’s on his mind:
JH: How have you seen Praxis change over the years?
BL: Where do I start? We’ve smartly ramped up staffing, services, and solutions to better serve our industry with an approach that never forgets our roots nor the people we serve. Our global reach, digital capabilities, and analytical proficiencies over the past five years have been incredible.
JH: How have you seen the industry change over the years?
BL: I’m constantly reminded that conducting good research is really hard, and, as such, more sponsors are proactively helping their research sites with targeted patient recruitment campaigns to support their enrollment efforts. I think this is why we’re seeing fewer studies drop into “rescue” mode. We’re also supporting a lot more rare/orphan and oncology studies, which has been particularly rewarding, especially because of the advocacy groups we’ve had the pleasure of working with.
JH: Where do you see the industry going in the next 5 years? 10 years?
BL: Clinical research awareness and literacy will continue to improve, and more physicians will discuss research options earlier with their patients. We’ll be even more targeted with outreach efforts, leveraging EMR, genetic insights, and AI. It’s my hope that we retire the image of the “guinee pig” before I retire.
JH: What is the most challenging aspect of your work?
BL: Not enough time in the day.
JH: What was your proudest moment/project you worked on at Praxis?
BL: Being recognized by PharmaVoice this year as one of the industry’s Most Inspiring People was both exciting and humbling. I’m also particularly proud of our philanthropic efforts, such as the full page ads in USA Today that we’ve produced for CISCRP the past 3 years to support awareness, literacy, and participation in clinical research.
JH: What is your advice for young professionals entering the pharmaceutical industry?
BL: Enroll in a study. Once you gain this perspective, your entire paradigm shifts, and you’ll understand your purpose and the patients we serve.
JH: Anything else you want to share?
BL: Just that I believe we (Praxis and our industry) are doing a much better job of humanizing clinical research participation. By evaluating all our work through the lens of the patient, we’re able to make powerful and insightful campaigns.